Premium
Peripheral blood stem cell mobilization by cytokines
Author(s) -
Ahmed Tauseef,
Wuest David,
Ciavarella David
Publication year - 1992
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.2920070306
Subject(s) - apheresis , mobilization , medicine , haematopoiesis , stem cell , peripheral blood , bone marrow , peripheral blood stem cells , chemotherapy , immunology , peripheral , cd34 , hematopoietic stem cell transplantation , platelet , transplantation , microbiology and biotechnology , biology , history , archaeology
Hematopoietic stem cells circulate in the peripheral blood. These cells can be collected by apheresis techniques either in the unperturbed state, after mobilization following the administration of cytokines like G‐CSF or GM‐CSF, or during the phase of early blood count recovery following chemotherapy‐induced myelosuppression. The number of cells collected following mobilization is greater than that obtained after apheresis in the unperturbed state. There are, however, qualitative differences between unperturbed and mobilized cells. Chemotherapy related mobilization can be potentially dangerous in that severe myelosuppression necessary to achieve mobilization can have serious consequences. There are no controlled studies that evaluate the relative merits of each method of collection. Regardless of the techniques employed peripheral blood stem cells can reliably accelerate hematologic recovery after potentially myeloblative therapy and provide an alternative to bone marrow support. © 1992 Wiley‐Liss, Inc.